Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |
mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.6 |
mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.6 |